Results 1 - 20 of 12,777 for All Library Resources
Sorted by:
Sorted by:
Date-newestOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
Refined by:
resource type:
Newsletter Articles
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Newsletter Article
|
|
Unity Biotechnology UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business UpdatesNews Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 16, 2024Digital Resources/Online E-Resources |
| 2 |
Material Type: Newsletter Article
|
|
Bruin Biometrics, LLC issued patent titled "Measurement of Edema"News Bites - Private Companies, 2024Copyright News Bites Pty Ltd May 16, 2024Digital Resources/Online E-Resources |
| 3 |
Material Type: Newsletter Article
|
|
Press Release: Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in StockholmDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 15, 2024Digital Resources/Online E-Resources |
| 4 |
Material Type: Newsletter Article
|
|
Unity Biotechnology (UBX: $1.55) decreases on average volume; -1.5c [1.0%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 15, 2024Digital Resources/Online E-Resources |
| 5 |
Material Type: Newsletter Article
|
|
Press Release: Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial ResultsDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 15, 2024Digital Resources/Online E-Resources |
| 6 |
Material Type: Newsletter Article
|
|
U.S. Patents Awarded to Inventors in New York (Jan. 3)Targeted News Service, 2024Targeted News ServiceDigital Resources/Online E-Resources |
| 7 |
Material Type: Newsletter Article
|
|
Calliditas Therapeutics: Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in StockholmDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 15, 2024Digital Resources/Online E-Resources |
| 8 |
Material Type: Newsletter Article
|
|
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track StatusJCN Newswire, 2024Copyright Japan Corporate News Network May 15, 2024Digital Resources/Online E-Resources |
| 9 |
Material Type: Newsletter Article
|
|
Press Release: Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business UpdateDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 15, 2024Digital Resources/Online E-Resources |
| 10 |
Material Type: Newsletter Article
|
|
Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in StockholmPR Newswire, 2024Copyright PR Newswire Association LLC May 15, 2024Digital Resources/Online E-Resources |
| 11 |
Material Type: Newsletter Article
|
|
BioCryst Reports First Quarter 2024 Financial Results and Provides Business UpdateEntertainment Close - Up, 2024Copyright Close-Up Media, Inc. May 15, 2024Digital Resources/Online E-Resources |
| 12 |
Material Type: Newsletter Article
|
|
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial ResultsPR Newswire, 2024Copyright PR Newswire Association LLC May 15, 2024Digital Resources/Online E-Resources |
| 13 |
Material Type: Newsletter Article
|
|
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business UpdateNASDAQ OMX's News Release Distribution Channel, 2024GlobeNewswire, Inc.Digital Resources/Online E-Resources |
| 14 |
Material Type: Newsletter Article
|
|
Press Release: Eisai Initiates Rolling Biologics -2Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 14, 2024Digital Resources/Online E-Resources |
| 15 |
Material Type: Newsletter Article
|
|
Press Release: Kite Data at EHA 2024 Demonstrate -5Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 14, 2024Digital Resources/Online E-Resources |
| 16 |
Material Type: Newsletter Article
|
|
Diabetic Macular Edema Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Roche, Kodiak Science, Graybug Vision's, Allergan, Inc., Quantel-MedicalM2 Presswire, 2024Copyright © M2 Communications, 2024Digital Resources/Online E-Resources |
| 17 |
Material Type: Newsletter Article
|
|
Press Release: Kite Data at EHA 2024 Demonstrate -3Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 14, 2024Digital Resources/Online E-Resources |
| 18 |
Material Type: Newsletter Article
|
|
Alimera Sciences (ALIM: $3.48) falls 2.1% on slipping relative strength; -7.5c [2.1%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 14, 2024Digital Resources/Online E-Resources |
| 19 |
Material Type: Newsletter Article
|
|
Press Release: Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI(R) (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track StatusDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 14, 2024Digital Resources/Online E-Resources |
| 20 |
Material Type: Newsletter Article
|
|
Press Release: Eisai Initiates Rolling Biologics -2Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 14, 2024Digital Resources/Online E-Resources |
Results 1 - 20 of 12,777 for All Library Resources
Sorted by:
Sorted by:
Date-newestOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
Refine My Results
Creation Date
- Before 2002 (29)
- 2002 To 2006 (98)
- 2007 To 2011 (567)
- 2012 To 2017 (2,130)
- After 2017 (9,953)
-
More options
New Records
- New From Last Week (19)
- New From Last Month (169)
- New From Last 3 Month (501)
-
More options
Subject
- Edema (12,770)
- Diabetes (6,143)
- Clinical Trials (3,155)
- Patients (2,683)
- Macular Degeneration (2,557)
- Pharmaceutical Industry (2,421)
- Fda Approval (2,154)
- Diabetic Retinopathy (2,095)
- Drug Dosages (1,966)
- Earnings Per Share (1,773)
- Net Losses (1,560)
- Biotechnology Industry (1,503)
- Ophthalmology (1,405)
- Stockholders (1,246)
- Webcasting (1,182)
- R&d (1,163)
- Research & Development (1,163)
- Retina (1,133)
- Eye Diseases (872)
- Pain (806)
-
More options
Databases
Language
- English (12,661)
- Spanish (103)
- Portuguese (12)
- Urdu (2)
- German (1)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||